insights_auto
Why is EDIT down 4.09%?
Dive Deeperchevron_right
EDIT:NASDAQ
Editas Medicine Inc
$1.64
arrow_downward
-4.09%(-0.070) 1D
$1.66
arrow_upward
+1.22% (+0.020)bedtimeAfter hours
Closed: Nov 20, 4:00:00 PM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for EDIT...
Open
$1.69
High
$1.78
Low
$1.63
Mkt. cap
253.12M
Avg. vol.
2.24M
Volume
2.68M
52-wk high
$3.94
52-wk low
$1.63
EPS
-$0.62
Beta
2.09
Shares outstanding
154.34M
No. of employees
87
Open
$1.69
High
$1.78
Low
$1.63
Mkt. cap
253.12M
Avg. vol.
2.24M
Volume
2.68M
52-wk high
$3.94
52-wk low
$1.63
EPS
-$0.62
Beta
2.09
Shares outstanding
154.34M
No. of employees
87
News stories
From web sources and news partners
The Motley Fool
·
59 minutes ago
The S&P 500 Heads Into Thanksgiving Below Its Peak. Here's How the Holiday Week Has Usually Gone Since 1950.
24/7 Wall St.
·
24 minutes ago
T-Bills Are Beating the Nasdaq, S&P 500 and Dow This Year
Traders Union
·
4 hours ago
Seventeen of the twenty largest S&P 500 drops began below the 200-day moving average, Ryan Detrick notes
cwibc.co.id
·
1 hour ago
S&P 500 Tech Sector Falls 23% Into Bear Market
Profile
Editas Medicine, Inc., is a clinical-stage biotechnology company that is developing therapies for rare diseases using CRISPR gene editing technology. Editas Medicine headquarters is located in Cambridge, Massachusetts with additional facilities in Boulder, Colorado. Wikipedia
About Editas Medicine Inc
CEO-
Employees87
FoundedNov 2013
Headquarters-
SectorHealth Care
IndustryBiotechnology
Websiteeditasmedicine.com